Dr. Joel Slaton's CV Page 3

Biography

Curriculum Vitae

Dr. Joel Slaton

(last updated 3/21/2003)

Previous----- | 1 | 2 | 3 | 4 | ------Next

________________________________________________________________________

CONTENTS OF PAGE 3

Papers; chapters and reviews
Publications (1-30)
Publications (31-60)
Publications (61-96)

Back to Contents

_________________________________________________________________________

Papers submitted or in preparation:

1. Slaton, J. W., Nelkin. G., and Killion, J. J., Therapy of lung metastases of murine renal adenocarcinoma with macrophage activator, CGP 31362, and IL-2 encapsulated into multilamellar liposomes. Submitted to Cancer Immunotherapy and Therapeutics.

2. Slaton, J.W. Perrotte, P, Inoue, K, Beilenberg, D, Eve, B, and Dinney, CPN, Interferon alpha restores the balance between the expression of MMP-9 and E-cadherin in human transitional cell carcinoma. Submitted to Cancer Research

3. Inoue, K., Wood, C.G., Slaton, J.W. and Colin P.N. Dinney. Interleukin-8 is a target for gene therapy in transitional cell carcinoma of the bladder. Submitted to Human Gene Therapy.

4. Slaton, J.W., Wood, C.G., Inoue, T. Karashima,, T., Davis, D.W., McConkey, D. and Dinney, C.P.N., Adenoviral-mediated gene therapy with antisense interleukin-8 for human prostate cancer.

5. Slaton, J.W., Inoue, K., Karashima, T., Tamashita, M.,, Pagliaro,, L., Benedict, W.F., and Dinney, C.P.N., Adenoviral p53 gene therapy enhances the efficacy of cytotoxic chemotherapy of transitional cell carcinoma of the bladder.

Chapters and reviews in preparation or in press:

1. Slaton, J.W. and Swanson, D.A., Radical Nephrectomy. In Comprehensive Textbook of Urologic Oncology. Eds Vogelzang, N. et al, 2000

2.. Slaton, J.W. and Swanson, D.A., Renal Cell Carcinoma: Diagnosis and Staging. In Current Clinical Oncology: Renal Cell Carcinoma: Molecular Biology, Immunology, and Clinical Management. Ed. R. M. Bukowski and A. C. Novick,, Humana Press Inc., Totowa, NJ, 2000.

3. Slaton, J.W., Swanson, D.A., Surgery for Metastatic Disease. In Renal and Adrenal Tumors - Biology and Management; eds Belldegrun, A, Figlin, RA, Vaughan E.D., Ritchie, A., and Oliver, T. (Oxford University Press). 2000.

4. Slaton, J.W., Benedict, W.F., and Dinney, C.P.N. p53: Mechanism of action, prognostic value, and target for therapy. In press in Urology.

Abstracts and Presentations (1-30):

1. Morris, J.A., Slaton, J.W., and Gibbs, D., Vascular organ procurement in the trauma population. Presented on the podium to the Eastern Association of Trauma Surgeons, 1/89
2. Slaton, J.W., Kropp, K.A., Jhunjhunwala, J.S., Wolfe, C., and Selman, S.H., Cyclosporine versus azathioprine: A five-year follow-up of 200 consecutive renal transplant recipients. Presented on the podium to the Ohio Urologic Society in 3/91 (honorable mention) and as a poster at the North Central Section of the American Urological Society in Phoenix, AZ in 11/91.
3. Slaton, J.W., Kropp, K.A., Merrick, H.W., and Selman, S.H., The use of ileal urinary conduits in conjunction with intraoperative radiotherapy. Presented on the podium at the North Central Section of the AUA in Phoenix, AZ in 11/91.
4. Slaton, J.W., Kropp, B P., Jhunjhunwala, J. S., Selman, S.H., Wolfe, C., and Kropp, K.A., Steroid complications in 200 consecutive renal transplant recipients:
Relationship to methylprednisolone pulse therapy. Presented on the podium to the Ohio Urological Society in 3/92.
5. Slaton, J.W., Hampton, J.A., and Selman, S.H., Inhibition of in vitro invasion of transitional cell carcinoma by exposure to alkyllysophospholipids. Presented on the podium to the Toledo Surgical Society 2/93 and Ohio Urological Society in 3/93; and as a poster at the 89th Annual American Urological Association in San Francisco, 5/94.
6. Slaton, J.W., and Kropp, K.A., Conservative management of suspected bladder perforations after augmentation enterocystoplasty. Presented on the podium to the North Central Section of the AUA , Millwaukee, WI, 10/93 and the Urology Section of the Academy of Pediatrics, Washington, DC, 11/93
7. Slaton, J.W., and Kropp, K. A., Ureteral stent migration: an avoidable complication? Presented on the podium to the Ohio Urological Society in 3/94 and North Central Section - AUA, 10/94.
8. Slaton, J.W., Murgia, M.G., Jordan, S., and Kahan, B.D., Rapamycin in conjunction with cyclosporine and steroids in HLA-DR mismatched living-related renal transplants. Presented on the podium at the 90th annual AUA in Las Vegas, 4/95. and at the Ortho Transplant Fellow Workshop in New Orleans, LA, 5/95.
9. Slaton, J.W., Browne, B.J., Lamki, L.M., Verani, R., Kahan, B.D., Tc-99m MAG3 renal scan predicts the presence of acute rejection but not the pathologic grade. Presented as a poster at the American Society of Transplant Physicians, Chicago, 5/95.
10.Slaton, J.W., Browne, B.J., Lamki, L.M., Kahan, B.D., Tc-99m MAG3 clearance predicts delayed graft function in renal transplants. Presented as a poster at the American Society of Transplant Physicians, Chicago, 5/95.
11. Lamki, L.M. Slaton, J.W., Browne, B.J., Barron, B., Kahan, B.D. Tc-99m MAG3 Clearance within 3 hours of renal transplatation is a good predictor of delayed graft function and risk of cyclosporine toxicity. Presented at annual meeting of the Radiological Society of North America 11/27/95 in Chicago, IL.
12. Lamki, L.M., Slaton, J.W., Browne, B.J., Barron, B., Kahan, B.D. Nuclear evaluation of renal allograft: prediction of delayed graft function by Tc-99m-MAG3 and of acute rejection by Tc-99m DTPA. Presented at the annual meeting of the Southwestern Chapter of the Society of Nuclear Medicine 3/30/96, Austin, TX.
13. Lamki, L.M., Slaton, J.W., Browne, B.J., Barron, B., Kahan, B.D. Tc-99m-MAG3 clearance at 3 hrs is a good predictor of delayed renal graft function (DGF) while Tc-99m-DTPA perfusion score during follow-up, can predict rejection. Presented at Society of Nuclear Medicine, 6/96, Denver, CO.
14. Slaton, J.W., Dinney, C.P.N., Liebert, M., Grossman, B., Miller, C., O'Dowd, G., Veltri, R. DNA ploidy enhances cytologic prediction of recurrences of transitional cell carcinoma of the bladder. Presented as a poster at the 91st AUA May, 1996 in Orlando, FL.
15. Levy, D.A., Slaton, J.W., Ellerhorst, J., Swanson, D. A., and Dinney, C. P. N., Feasibility of cytoreductive surgery prior to systemic biologic therapy in carefully selected metastatic renal cell carcinoma. Presented as a poster at the 92nd Annual AUA in New Orleans, 4/97.
16. Levy, D.A., Slaton, J.W., Swanson, D.A., and Dinney, C.P.N. A stage-based protocol for surveillance in patients with local renal cell carcinoma (RCC). Presented as a poster at the 92nd Annual AUA in New Orleans, 4/97.
17. Donat, S.M. and Slaton, J.W. Early nasogastric removal in conjunction with reglan after radical cystectomy and urinary diversion. Presented on the podum at the 92nd Annual AUA in New Orleans, 4/97.
18. Veltri, R.W., Miller, M.C., Slaton, J.W., Dinney, C.P.N., Liebert, M., Grossman, H.B., and O'Dowd, G.J. Computer-assisted quantitative nuclear grading (QNG) can predict bladder cancer recurrence using bladder cancer cytology samples. Presented as a poster at the 92nd Annual AUA in New Orleans, 4/97.
19. Slaton, J.W., Dinney, C.P.N., and Grossman, H.B. A stage-based protocol for tumor surveillance after radical cystectomy. Presented as a poster at the 92nd Annual AUA in New Orleans, 4/97.
20. Slaton, J.W., Levy, D.A., Dinney, C.P.N., Swanson, D.A., and Grossman, H. B. Stage-driven surveillance protocols for recurrence of renal and bladder cancer after definitive local surgery. Presented as a poster to the 1st Annual MDACC Trainees Competition, Houston, TX, May, 1997.
21. Slaton, J.W., Balbay, M.D., Levy, D.A., Nesbitt, J.C., Swanson, D.A., Pisters, L.L., and Dinney, C.P.N., Nephrectomy and vena caval thrombectomy in patients with metastatic renal cell carcinoma. Presented on the podium to the Canadian Urological Association, Quebec City, 6/97 and South Central Section of AUA, Bermuda, November, 1997
22. Slaton, J.W., Levy, D.A., El-Neggar, A, Swanson, D. A., and Dinney, C.P.N., The predictive value of DNA ploidy in conjunction with other prognostic factors for recurrent renal cell carcinoma. Presented as a poster to the South Central Section of the AUA, Bermuda, November, 1997
23. Slaton, J.W., Perrotte, P., Bielenberg, D., Eve, B.Y., Inoue, K., Fidler, I.J., and Dinney, C.P.N., Dosing interval of alpha-interferon is critical in the downregulation of angiogenesis and invasive factors in orthotopically implanted human transitional cell carcinoma. Presented as a poster at the 88th Annual AACR Annual Meeting, New Orleans, LA, March, 1998
24. Killion, J.J., Slaton, J.W. and Nelkin, G. Generation of antitumor effector macrophages and LAKAg cells and inhibition of lung metastasis of murine renal adenocarcinoma (RENCA) with Multilamellar liposomes (MLV) which contain both lipopeptide CGP31362 and interleukin-2. Presented as a poster at the 88th Annual AACR Annual Meeting, New Orleans, LA, March, 1998.
25. Slaton, J.W., Levy, David A. , Morris, M., Swanson, D.A., Grossman, H.B., Dinney, C.P.N. Cost analysis of a stage-specific approach to tumor surveillance after radical surgery for genitourinary neoplasms. Presented on the podium at the 93rd Annual AUA at San Diego, CA, April, 1998.
26. Dinney, C.P.N., Perrotte, P., and Slaton, J.W., Impact of adjuvant chemotherapy on long-term survival of patients with lymph node metastases after radical cystectomy. Presented on the podium at the 93rd Annual AUA at San Diego, CA, April, 1998.
27. Levy D.A., Slaton, J.W., Perrotte, P., El-Naggar, A., Swanson, S.A., Dinney, C.P.N. The value of DNA ploidy in conjunction with other prognostic factors for the prediction of tumor recurrence in renal cell carcinoma (RCC). Presented as a poster at the 93rd Annual AUA at San Diego, CA, April, 1998.
28. Slaton, J.W., Nelkin, G., and Killion, J.J., Incorporation of interleukin-2 into liposomes containing macrophage activators as therapy for lung metastases of murine renal cell carcinoma (RENCA). Presented as a poster at the 93rd Annual AUA at San Diego, CA, April, 1998.and at 2nd Annual MDACC Trainees Competition, Houston, TX, May, 1997
29. Miller, M. C., O-Dowd, G.J., Veltri, R.W., Slaton, J.W., Dinney, C.P.N., and Grossman, H.B., The effect of intravesical Bacillus Calmette-Guerin (BCG) on the predictive value of cytology and DNA ploidy. Presented as a poster at the 93rd Annual AUA at San Diego, CA, April, 1998.
30. Ellerhorst, J., Slaton, J.W., Perrotte, P., Dinney, C.P.N., and Swanson, D.A., Integration of metastasectomy into a multimodal approach for the treatment of metastatic renal cell carcinoma (RCC). Presented as a poster at the 93rd Annual AUA at San Diego, CA, April, 1998.

Articles and Presentations (31-60):

31. Perrotte P., Slaton, J.W. , Ellerhorst, J, and Dinney, C.P.N., The rationale for renal biopsy in symptomatic patients with advanced renal cell carcinoma being considered for nephrectomy. Presented as a poster at the 93rd Annual AUA at San Diego, CA, April, 1998.
32. Diane Bielenberg, Perrotte, P., Slaton, J. W., Eve, B.Y., Inoue, K., and Dinney, C.P.N., Systemic administration of interferon-alpha decreases expression of metalloproteinase type 9 (MMP-9), angiogenesis and growth of human transitional cell carcinoma growing in athymic nude mice. Presented as a poster at the 93rd Annual AUA at San Diego, CA, April, 1998.
32. Corral, D.A., Slaton, J.W., Perrotte, P., Dinney, C.P.N., and Grossman, H.B., The role of examination under anesthesia (EUA) in the staging and management of bladder cancer in the contemporary era. Presented on the podium at the 93rd Annual AUA at San Diego, CA, April, 1998.
33. Inoue, K., Slaton, J.W., Perrotte, P., El-Naggar, A., Pisters, L.L., and Dinney, C.P.N., The relationship of hepatocyte growth factor receptor (C-met) expression to metastasis and progression in primary and metastatic renal cell carcinoma (RCC). Presented as a poster at the 93rd Annual AUA at San Diego, CA, April, 1998.
34. Killion, J.J., Slaton, J.W., and Nelkin, G. Effector cell activation against murine renal cell adenocarcinoma and subsequent release of cytokines induced by liposome-encapsulated IL-2 and CGP31362. Presented at the Second Joint Meeting of the International Cytokine Society and International Society for Interferon and Cytokine Research. Jerusalem, Israel. Oct 26, 1998.
35. Killion, J.J., Slaton, J.W., Wilson, M.R., Pathak, S., Nelson, G. and Greenberg, N.M. Establishment and characterization of an orthotopic, therapeutic model of prostate pancer by Implantation of TRAMP C-2 cells in the prostate of syngeneic C57BL/6 mice. Presented at AACR special conference "New Research Approaches in the Prevention and Cure of Prostate Cancer" in Indian Wells, CA December 3, 1998.
36. Inoue K., Slaton, J.W., Eve, B.Y., Perrotte, P., Balbay, M.D., and Dinney, C.P.N., Interleukin-8 expression regulates tumorigenicity and metastases in human bladder and prostate cancer. Presented as a poster at the 89th Annual AACR in Philadelphia, PA, April, 1999.
37. Slaton, J.W., Perrotte, P., Inoue, K., El-Naggar, A., Fidler, I.J., and Dinney, C.P.N. Relative expression of collagenase type IV and E-cadherin in radical nephrectomy specimens can predict for advanced pathologic stage. Presented as a poster at the 89th Annual AACR in Philadelphia, PA, April, 1999.
38. Inoue, K., Kim, Y-B., Slaton, J.W., Portera, C.A., Kassis, J., Ells, A., Dinney, C.P.N., and Radinsky, R. Overexpression of a motility-deficient epidermal growth factor receptor (EGF-R) in human transitional cell carcinoma (TCC) inhibits matrixmetalloprotease-9 (MMP-9)-mediated motility, angiogenesis, and metastasis in nude mice. Presented at a minisymposium at the 89th Annual AACR in Philadelphia, PA, April, 1999.
39. Karashima, T., Chiaki Yoshikawa, Shuin, T., Inoue, K., Slaton, J.W., and Dinney, C.P.N., The prognostic value of angiogenic factors for progression after cystectomy for muscle-invasive bladder cancer. Presented on the podium at the 94th Annual AUA in Dallas, TX, May, 1999.
40. Killion, J.J., Slaton, J.W., Wilson, M.R., Pathak, S., Nelkin, G., and Greenberg, N.M., Development of an immunocompetent therapeutic model of prostate cancer by implantation of TRAMP C-2 cells in the prostate of syngeneic C57BL/6 mice. Presented as a poster at the 94th Annual AUA in Dallas, TX, May, 1999.
41. Dinney, C.P.N., Slaton, J.W., Inoue, K., Perrotte, P., El-Naggar, A., Fidler, I.J., Swanson, D.A., and Dinney, C.P.N., The prognostic significance of angiogenic factor expression in renal cell carcinoma (RCC). Presented as a poster at the 94th Annual AUA in Dallas, TX, May, 1999.
42. Pavlovich, C.P., Vaughan, E.D., Jr., Kadesky, K., Slaton, J.W., Swanson, D.A., and Dinney, C.P.N., A stage-specific surveillance protocol for patients after nephroureterectomy for upper tract transitional cell carcinoma: a multiinsitutional analysis. Presented as a poster at the 94th Annual AUA in Dallas, TX, May, 1999.
43. Radinsky, R., Inoue, K., Slaton, J.W., Kim, Y-B, Portera, C.A., Dinney, C.P.N.; Kassis, J. and Wells, A., Overexpression of a motility-deficient epidermal growth factor receptor (EGF-R) in human transitional cell carcinoma (TCC) inhibits matrixmetalloprotease-9 (MMP-9)-mediated motility, angiogenesis, and metastasis in nude mice. Presented as a poster at the 94th Annual AUA in Dallas, TX, May, 1999.
44. Morgenstern, N., Slaton, J.W., Levy, D.A., Ayala, A.,Santos, M.W. Jr., and Pettaway, C.A., Vascular invasion and tumor stage are independent prognosticators of lymph node metastasis in squamous penile cancer (SPC). Presented on the podium at the 94th Annual AUA in Dallas, TX, May, 1999.
45. Rodriguez-Villanueva, J., Slaton, J.W., Grossman, H.B. Fritsche, H.A. and Dinney, C.P.N., The effect of Bacille-Calmette Guerin (BCG) on the specificity of nuclear matrix protein 22 (NMP22) for recurrent bladder cancer. Presented as a poster at the 94th Annual AUA in Dallas, TX, May, 1999.
46. Inoue K., Slaton, J.W., Perrotte P., Eve B.Y., and Dinney C.P.N., Interleukin-8 (IL-8) expression regulates tumorigenicity and metastases in human bladder cancer. Presented as a poster at the 94th Annual AUA in Dallas, TX, May, 1999.
47. Inoue K., Eve B.Y., Slaton, J.W., Perrotte P., Balbay M.D., Pettaway C.A., and Dinney C.P.N. Interleukin-8 (IL-8) expression regulates metastases in androgen independent prostate cancer Presented as a poster at the 94th Annual AUA in Dallas, TX, May, 1999.
48. Dinney, C.P.N., Slaton, J.W., Perrotte, P., Ellerhorst, J. and Swanson, D.A., The effect of organ site on survival after resection of a solitary renal cell carcinoma (RCC) metastasis. Presented as a poster at the 94th Annual AUA in Dallas, TX, May, 1999.
49. Pettaway, C.A., Pisters, L.L., Finn, D., Slaton, J. W., and Logothetis, C.J., Preoperative chemotherapy (CHT) and hormonal therapy (AA) followed by radical prostatectomy for locally advanced prostate cancer (PCA). Presented as a poster at the 94th Annual AUA in Dallas, TX, May, 1999.
50. Slaton, J.W., Perrotte, P., Inoue, K., El-Naggar, A., Fidler, I.J., Swanson, D.A., and Dinney, C.P.N., Ratio of matrix metalloproteinases (MMP) to E-cadherin (Ecad) expression is an independent predictor of metastasis in renal cell carcinoma (RCC). Presented as a poster at the 94th Annual AUA in Dallas, TX, May, 1999.
51. Balbay, M.D., Slaton, J.W., Trane, N., Skibber, J., and Dinney, C.P.N. Avoiding urinary diversion in patients with locally advanced rectal cancer: The role for bladder sparing. Presented on the podium at the 94th Annual AUA in Dallas, TX, May, 1999.
52. Perrotte, P., Wood, C.G., Inoue, K., Slaton, J.W., and Dinney, C.P.N. Basic fibroblast growth factor as a target for gene therapy in transitional cell carcinoma of the bladder bFGF gene therapy. Presented as a poster at the 94th Annual AUA in Dallas, TX, May, 1999.
53. Perrotte, P., Inoue, K., Slaton, J.W., Eve, B., and Dinney, C.P.N. Intralesional interferon gene transfer inhibits the growth of human transitional cell carcinoma (TCC) growing in athymic nude mice by inhibition of angiogenesis and activation of macrophages. Presented as a poster at the 94th Annual AUA in Dallas, TX, May, 1999.
54. Slaton, J.W., Perrotte, P., Ellerhorst, J. Dinney, C.P.N. and Swanson, D.A. Survival after resection of a solitary renal cell carcinoma (RCC) metastasis is dependent upon the site of metastasis. Presented as a poster at the First International Symposium on Renal Cancer. Chicago. IL Oct 2, 1999.
55. Slaton, J.W., Inoue, K. Perrotte, P., El-Naggar, A. K., Swanson, D.A. and Dinney, C.P.N., Metastasis-related gene expression in primary renal cell carcinoma Presented as a poster at the First International Symposium on Renal Cancer. Chicago. IL Oct 2, 1999.
56. Inoue, K., Slaton, J.W., Davis, D.W., Hicklin, D.J., McConkey, D., Karashima, T., Radinsky, R., and Dinney, C.P.N. Therapy of metastatic transitional cell carcinoma of the bladder with the anti-vascular endothelial cell growth factor receptor (flk1/KDR) monoclonal antibody DC101 and paclitaxel. Presented as a poster at Molecular Targets and Cancer Therapeutics, Washington, D.C. Nov 17, 1999 and at Cancer Research at the Millenium in Houston, TX Jan 10, 1999.
57. Inoue, K., Slaton, J.W., Perrotte, P., Davis, D.W., Bruns, C.J., Hicklin, D.J., McConkey, D., Karashima, T., Radinsky, R., and Dinney, C.P.N. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody C225 in mice with metastatic human bladder transitional cell carcinoma. Presented as a poster at Molecular Targets and Cancer Therapeutics, Washington, D.C. Nov 17, 1999 and at Cancer Research at the Millenium in Houston, TX Jan 10, 1999.
58. Inoue, K., Slaton, J.W., Perrotte, P., Bruns, C.P., Davis, D.W., Hicklin, D.J., McConkey, D., Karashima, T. , Radinsky, R. and Dinney, C.P.N. Anti-epidermal growth factor receptor monoclonal antibody C225 enhances the effect of paclitaxel on metastatic human transitional cell carcinoma. Presented at the 91st Annual AACR in San Francisco, April 1-4, 2000.
59. Karashima, T., Inoue K., Slaton, J.W., Perrotte, P., Wood, C.G., Eve, B. and Dinney, C.P.N. Therapy with adenoviral-mediated antisense bFGF and IL-8 cDNA constructs can inhibit tumor-induced angigoenesis and tumor growth of human transitional cell carcinoma. Presented at the 91st Annual AACR in San Francisco, April 1-4, 2000.
60. Slaton, J.W., Inoue K., Slaton, J.W., Karashima, T. Moti, Pagliaro, L. Benedict, W.F. and Dinney, C.P.N. Therapy with an adenoviral p53 construct enhances cytoreductive chemotherapy of transitional cell carcinoma by augmenting apoptosis and inhibiting of angiogenesis. Presented at the 91st Annual AACR in San Francisco, April 1-4, 2000.

Articles and Presentations (61-96):

61. Killion, J.J., Slaton, J.W., Nelkin, G. Cytokine profile of spleen cells stimulated with liposomal-lipopeptide and IL-2 rapid release if IFN-g, continuous release of TNF-a an dproperties of cellular paralysis to release of cytokines. Presented at the 91st Annual AACR in San Francisco, April 1-4, 2000.
62. Slaton, J.W., Inoue, K. Yoshikawa, C., Shuin, T. Karashima,, T. and Dinney, C.P.N. The ratio of matrix metalloproteinase-9 to e-cadherin is an independent predictor
of disease-free survival in transitional cell carcinoma of the bladder. Presented on the podium at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
63. Slaton, J.W., Perrotte, P., Balbay, M. D., Levy, D.A.Dinney, C.P.N. and Swanson, D.A. A reassessment of the selection criteria for cytoreductive nephrectomy in patients with metastatic renal cell carcinoma. Presented as a poster at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
64. Izawa, J., Slaton, J.W., Czerniak, B., and Dinney, C.P.N. Differential expression of metastasis-related genes in invasive and superficial bladder tumors. Presented as a poster at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
65. Karashima,, T., Slaton, J.W., Fan, Z., Mendelsohn, J. and Dinney, C.P.N. Inhibition of angiogenesis by the anti-epidermal growth factor receptor antibody c225 in androgen independent prostate cancer growing orthotopically in nude mice. Presented as a poster at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
66. Karashima, T., Slaton, J.W., Kim, S.J., and Dinney, S.J. Low-dose interferon-a inhibits tumor-induced neovascularity and growth after chemotherapy-induced cytoreduction of transitional cell carcinoma growing in the bladder wall of athymic nude mice. Presented as a poster at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
67. Inoue, K., Slaton, J.W., Davis, D. W., Bruns, C.J., Radinsky, R., Kim S.J., Dinney, C.P.N. and Hicklin, D.J. Epidermal growth factor receptor antibody (IMC-C225) enhances paclitaxel therapy of orthotopic transitional cell carcinoma growing in nude mice. Presented as a poster at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
68. Inoue, K., Slaton, J.W., Radinsky, R., Dinney, C.P.N., and Hicklin, D.J. Vascular endothelial growth factor receptor antibody (DC101) is synergistic with paclitaxel in the treatment of human transitional cell carcinoma growing in the bladder of nude mice. Presented as a poster at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
69. Slaton, J.W., Inoue, K., Karashima, T., Tamashita, M., Pagliaro,, L., Benedict, W.F., and Dinney, C.P.N., Adenoviral p53 gene therapy enhances the efficacy of cytotoxic chemotherapy of transitional cell carcinoma of the bladder by increasing apoptosis and inhibiting angiogenesis. Presented as a poster at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
70. Wood, C.G., Slaton, J.W., Inoue, T. Karashima,, T., Davis, D.W., McConkey, D. and Dinney, C.P.N., Adenoviral-mediated gene therapy with antisense interleukin-8 for human prostate cancer. Presented as a poster at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
71. Slaton, J.W., Inoue, K., Tamoli, P., El-Naggar, A.K., Swanson, Dinney, C.P.N., Progression-related gene expression in resected renal cell carcinoma lung metastases. Presented as a poster at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
72. Slaton, J.W., Babaian, R.J., Bochner, B.H., Lieskovsky, G. and Skinner, D.G., Risk factor-directed surveillance for prostate specific antigen recurrence after radical prostatectomy for localized prostate cancer. Presented as a poster at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
73. Slaton, J.W., Inoue, K., Morganstern, N., Tamboli, P., Ayala, A., Dinney, C.P.N. and Pettaway, C.A., Metastasis-related gene expression predicts for positive inguinal lymph nodes in squamous penile carcinoma. Presented on the podium at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
74. Slaton, J.W., Millikan, R., Inoue, K., Czerniak, B. and Dinney, C.P.N., Metastasis-related gene expression predicts for survival in patients with locally advancedtransitional cell carcinoma undergoing systemic chemotherapy and radical cystectomy. Presented on the podium at the 95th Annual AUA in Atlanta, May 2-6, 2000
75. Bevan-Thomas, R., Slaton, J.W., and Pettaway, C.A., Morbidity of inquinal lymphadenectomy for squamous penile carcinoma in the contemporary era. Presented on the podium at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
76. Inoue, K., Wood, C.G., Slaton, J.W. and Colin P.N. Dinney. Interleukin-8 is a target for gene therapy in transitional cell carcinoma of the bladder. Presented as a poster at the 5th Annual AUA in Atlanta, April 28-May 4, 2000.
77. Slaton, J.W., Okihara,, K., Troncoso, P. and Babaian R.J., A novel strategy for selecting patients for nerve-sparing radical prostatectomy. Presented as a poster at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
78. Sintuu, C., Inoue, K., Slaton, J.W., Pettaway, C.A., Dinney, C.P.N., and Wood, C.G. Angiogenesis as a target for adenoviral-mediated antisense gene therapy in urologic malignancies. Presented as a poster at the 95th Annual AUA in Atlanta, April 28-May 4, 2000.
79. Mian B., Amato R., Slaton J.W., and Pister L.L., Sarcomatoid renal cell carcinoma: The effect of multimodal therapy in the contemporary era. Presented on the podium at the South Central Section of the AUA in Montreal, Sept. 10, 2000.
80. Slaton, J.W., Inoue, K., Morganstern, N., Tamboli, P., Ayala, A., Dinney, C.P.N. and Pettaway, C.A., Metastasis-related gene expression predicts for positive inguinal lymph nodes in squamous penile carcinoma. Presented on the podium at the South Central Section of the AUA in Montreal, Sept. 9, 2000.
81. Inoue, K, Slaton J.W., Dinney, C.P.N., Karashima T., Yoshikawa C., and Shuin, T. The prognostic value of angiogenesis factor expression for predicting progression of locally advanced bladder cancer following neoadjuvant chemotherapy and readical cystectomy. Presented on the podium at the South Central Section of the AUA in Montreal, Sept. 9, 2000.
82. Bevan-Thomas, R., Slaton, J.W., and Pettaway, C.A., Contemporary morbidity of inquinal lymphadenectomy for squamous penile carcinoma. Presented on the podium at the South Central Section of the AUA in Montreal, Sept. 9, 2000.
83. Swanson D.A., Slaton J.W., Babaian R.J.,Pettaway C.A., Pisters LL, and wood CG. Early biochemical failure after radical prostatectomy for apparently localised prostate cancer does not always represent distant metastatic disease. Presented at the Society International Urologique in Singapore, Oct 29 2000.
84. Babaian RJ, Slaton, J.W., Okihara,, K., and Troncoso, P. A novel strategy for selecting patients for nerve-sparing radical prostatectomy. Presented at the Society International Urologique in Singapore, Oct 30 2000.
85. Swanson D.A., Slaton J.W., Dinney C.P.N. Selection criteria for cytoreductive nephrectomy in patients with metastatic renal cell carcinoma. Presented at the Society International Urologique in Singapore, Oct 30 2000.
86. Slaton, J.W., Wood, C.G., Kedar D., Karashima, T., and Dinney, C.P.N. Vascular endothelial growth factor is a target for gene therapy in bladder cancer. To be presented as a poster at the 96th Annual AUA in Anaheim, June 1-6, 2001.
87. Slaton, J. W., Karashima, T, Perrotte P., Inoue K., Kedar D., McConkey D., Millikan, R., Yoshikawa C., Shuin T., and Dinney, C.P.N. Therapy with low-dose interferon-alpha (IFN-alpha) can restore the normal balance between MMP-9 and E-cadherin expression in human transitional cell carcinoma of the bladder To be presented as a poster at the 96th Annual AUA in Anaheim, June 1-6, 2001.
88. Slaton, J.W., Keiji I, Tamboli P., El-Naggar A.K., Swanson D.A., and Dinney, C.P.N.,
Impact of organ site on progression-related gene expression in resected renal cell carcinoma metastases. To be presented as a poster at the 96th Annual AUA in Anaheim, June 1-6, 2001.
89. Kim S.J., Karashima, T , Slaton, J.W., Keiji I, and Dinney, C.P.N., Low-dose interferon-alpha inhibits tumor-induced neovascularity and growth after chemotherapy-induced cytoreduction of androgen-independent prostate cancer. To be presented as a poster at the 96th Annual AUA in Anaheim, June 1-6, 2001.
90. Slaton J.W., Okihara K., Frost J., Troncoso J. and Babaian R.J. A color-labeling strategy for cost-effective site-specific identification of prostate sextant biopsy cores. To be presented as poster at the 96th Annual AUA in Anaheim, June 1-6, 2001.
91. Slaton, J.W., Huang S.F., Levy D.A., and Pettaway C.A.. Lymph node-positive squamous penile carcinoma: Extent of nodal involvement predicts 3-year disease-free survival. To be presented on the podium at the 96th Annual AUA in Anaheim, June 1-6, 2001.
92. Slaton, J.W.., Levy D.A.,, Perrotte P., Dinney C.P.N., and Swanson D.A. Practical application of renal cell carcinoma prognostic factors to a risk factor driven approach to tumor surveillance after radical nephrectomy To be presented as a poster discussion at the 96th Annual AUA in Anaheim, June 1-6, 2001.
93. Slaton JW, Inoue K, Perrotte P, El-Naggar A, Swanson DA, Dinney CPN High expression of progression-related genes in resected renal cell carcinoma lung metastases is associated with decreased disease-free survival. To be presented at the 92nd Annual AACR in New Orleans, March 24-29, 2001
94 Kedar DM, Slaton JW, Dinney CPN, Killion JJ, Fidler IJ 0ptimal biological dose of pegilated interferon-alpha (PEG-IFN-alpha) inhibits angiogenesis and growth of human transitional cell carcinoma in the bladder of nude mice. To be presented at the 92nd Annual AACR in New Orleans, March 24-29, 2001.
95. Killion JJ, Slaton JW, Nelkin G, Tumoricidal activation of macrophages and effector cells by liposome-encapsulated (MLV) CGP31362 and IL-2 results in inhibition of lung metastasis of murine renal adenocarcinoma (RENCA). To be presented at the 92nd Annual AACR in New Orleans, March 24-29, 2001.
96. Huang S.F., Slaton JW, Tamboli P., Song R., Kedar D., Sweeney P., Mian B., Pettaway CA. Development and characterization of a novel orthotopic model of penile squamous carcinoma in nude mice. To be presented at the 92nd Annual AACR in New Orleans, March 24-29, 2001.

Previous----- | 1 | 2 | 3 | 4 | ------Next